Home » Topics » BioWorld Science

BioWorld Science
RSS

Antidiabetic activity of beta3-adrenoceptor agonist BRL-37344 elucidated in vitro

Sep. 19, 1997

Asta Medica and Wyeth-Ayerst agreement for epilepsy drug

Sep. 18, 1997

U.S. introduction for FemPatch

Sep. 18, 1997

October launch for Zanaflex in U.K.

Sep. 18, 1997

Dopamine D1/D2 coactivation maximizes metabolic responses in obese mice

Sep. 18, 1997

Oxford GlycoSciences' OGT-719 enters clinical testing

Sep. 18, 1997

TheraTech and Astra sign agreement for Androderm distribution

Sep. 18, 1997

Potent and selective N-type calcium channel blockers for stroke

Sep. 18, 1997

New raloxifene analogue from Lilly is a potent SERM

Sep. 18, 1997

Efavirenz/indinavir combination shows efficacy in phase II

Sep. 18, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Aug. 3, 2026.
Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors
BioWorld Science
Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
Death in Chinese gene-editing trial exposes ethical fault lines
BioWorld
The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
Seed funding at Adjuvia to treat mitochondrial dysfunction
BioWorld Science
Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
Replimune’s RP-1 for melanoma wins over FDA adcom
BioWorld
Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...